Share
News

Country Announces Cancer Vaccines 'Close,' Could Soon Be Available to Patients

Share

Medical researchers have been searching for a cure for cancer for decades, but so far, success has been spotty. Now, however, one country is claiming that its medical scientists are “close” to a vaccine that would prevent the dreaded disease.

On Wednesday, Russian President Vladimir Putin made the surprising announcement at a Moscow forum on future technologies that his country is about to make medical history, Reuters reported.

Putin told his audience that “we have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation.”

“I hope that soon they will be effectively used as methods of individual therapy,” he said.

The Russian president did not clarify which types of cancer his vaccines would treat or how they might work.

Trending:
Election Coverage 2024

The idea of a vaccine that would work to prevent cancer is not a new one.

Medical researchers in the United Kingdom are working on clinical trials for”personalised cancer treatments” in cooperation with Germany-based BioNTech. The process, though, is long-term, with a goal of reaching 10,000 patients by 2030, Reuters noted.

Pharmaceutical companies Moderna and Merck & Co. are working on a cancer vaccine in the United States. Midstage trial data released in December indicated the vaccine might cut the risk of melanoma recurrence by half after three years of treatment, according to CNBC.

There are already vaccines that attack the human papillomavirus, a sexually transmitted disease that can lead to cancerous growths of various types, including cervical cancer.

Do you believe Putin?

But researchers are close to effective treatments in many areas.

In 2022, a promising cancer treatment for rectal cancer was put into clinical trials at Memorial Sloan Kettering Cancer Center in New York City.

The New York Times reported at the time that the treatment on the test subjects was 100 percent successful and that the cancer had “vanished” in every patient.

Researcher Dr. Luis A. Diaz Jr. said it was the first time in medical history that such a miraculous result was ever seen.

The drug, Jemperli, reportedly “unmasks cancer cells, allowing the immune system to identify and destroy them,” the Times reported.

Related:
Pakistanis Make Grisly Discovery in Location Known for Beauty, Immediately Contact Japanese Officials

Last year, other researchers said they found that DNA therapies could lead to doctors being able to target and eliminate cancer cells.

A study from the University of Tokyo published by the Journal of the American Chemical Society found that a special strand of DNA injected into cancer cells helped unravel the cancerous growth and allowed the cells to be destroyed by an immune response.

“We found that the products from the hairpin DNA assembly selectively kill miR-21-abundant cancer cells in vitro and in vivo based on innate immune activation,” the research paper said.

Some of the early findings in all these cancer efforts are promising. Scientists could, at long last, be on the cusp of some serious breakthroughs in the fight against deadly cancers.


An Important Message from Our Staff:

 

In just a few months, the world is going to change forever. The 2024 election is the single most important election of our lifetime. 

 

We here at The Western Journal are committed to covering it in a way the establishment media simply will not: We will tell the truth, and they will lie.

 

But Big Tech and the elites don’t want the truth out. That’s why they have cut us off from 90% of advertisers. Imagine if someone cut your monthly income by 90%. That’s what they’ve done to people like us. 

 

As a staff, we are asking you to join us to fight this once-in-a-lifetime fight. Without you not only will The Western Journal fail, but America will fail also. As Benjamin Franklin said, “We must all hang together, or assuredly we shall all hang separately.”

 

Will you support The Western Journal today and become a member

 

A Western Journal Membership costs less than one coffee and breakfast sandwich each month, and it gets you access to ALL of our content — news, commentary, and premium articles. You’ll experience a radically reduced number of ads, and most importantly you will be vitally supporting the fight for America’s soul in 2024.

 

This is the time. America will live or die based on what happens this year. Please join us to get the real truth out and to fight the elites, Big Tech, and the people who want America to fail. Together, we really can save the country.

 

Thank you for your support!

 

P.S. Please stand with us!

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , , , , ,
Share
Warner Todd Huston has been writing editorials and news since 2001 but started his writing career penning articles about U.S. history back in the early 1990s. Huston has appeared on Fox News, Fox Business Network, CNN and several local Chicago news programs to discuss the issues of the day. Additionally, he is a regular guest on radio programs from coast to coast. Huston has also been a Breitbart News contributor since 2009. Warner works out of the Chicago area, a place he calls a "target-rich environment" for political news. Follow him on Truth Social at @WarnerToddHuston.
Warner Todd Huston has been writing editorials and news since 2001 but started his writing career penning articles about U.S. history back in the early 1990s. Huston has appeared on Fox News, Fox Business Network, CNN and several local Chicago news programs to discuss the issues of the day. Additionally, he is a regular guest on radio programs from coast to coast. Huston has also been a Breitbart News contributor since 2009. Warner works out of the Chicago area, a place he calls a "target-rich environment" for political news.




Advertise with The Western Journal and reach millions of highly engaged readers, while supporting our work. Advertise Today.

Conversation